These rare infections can progress quickly leading to serious and life threatening infections, including sepsis, soft-tissue necrosis, toxic shock syndrome and meningitis.
Annual data from the Public Health Agency of Canada shows a record number of bacterial infections that have been deadly in rare cases, especially among children.
Study evaluates efficacy of one and two doses of recombinant zoster vaccine overall, by time since vaccination, age and immunocompromise status, and with a late second dose.
